A Reversal for Cellect Biotechnology LTD. – American Depositary S (NASDAQ:APOP) Is Not Near. The Stock Has Rise in Shorts

September 16, 2018 - By Eula Gilbert

The stock of Cellect Biotechnology LTD. – American Depositary S (NASDAQ:APOP) registered an increase of 6.44% in short interest. APOP’s total short interest was 44,600 shares in September as published by FINRA. Its up 6.44% from 41,900 shares, reported previously. With 22,400 shares average volume, it will take short sellers 2 days to cover their APOP’s short positions. The short interest to Cellect Biotechnology LTD. – American Depositary S’s float is 0.07%.

The stock decreased 1.42% or $0.07 during the last trading session, reaching $4.87. About 8,312 shares traded. Cellect Biotechnology Ltd. (NASDAQ:APOP) has declined 41.02% since September 16, 2017 and is downtrending. It has underperformed by 56.64% the S&P500.

Cellect Biotechnology Ltd., a biotechnology company, focuses on developing technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel. The company has market cap of $31.70 million. It is developing the Apotainer selection kit, a shelf stem cell selection kit, based on its Powered by Cellect technology platform for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. It currently has negative earnings.

Another recent and important Cellect Biotechnology Ltd. (NASDAQ:APOP) news was published by Benzinga.com which published an article titled: “38 Stocks Moving In Tuesday’s Mid-Day Session” on September 04, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.